Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06264726 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CommunityRx-Cardiovascular Disease

Study acronym: CRx-CVD
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Results posted: Sep 24, 2026 Eligibility criteria expanded, about 24 words · Secondary endpoints revised (2) · Primary endpoint revised Show 3 more changesShow less
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints revised (2)
    • Primary endpoint revised
  2. Trial status: Active, Not Recruiting to Completed Enrollment target: estimated 325 to confirmed 308 · Primary and study completion dates changed from estimate of Oct 30, 2025 to Oct 28, 2025v4 Show 2 more changesShow less
    • Enrollment target: estimated 325 to confirmed 308
    • Primary and study completion dates changed from estimate of Oct 30, 2025 to Oct 28, 2025
  3. Primary and study completion dates: Mar 12, 2025 to Oct 30, 2025 Trial status: Recruiting to Active, Not Recruiting · Site details revised at 2 of 2 sitesv3 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
  4. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Feb 19, 2025 to Mar 12, 2025 · Start date changed from estimate of Feb 19, 2024 to Mar 12, 2024 · Site details revised at 2 of 2 sitesv2 Show 3 more changesShow less
    • Primary and study completion dates: Feb 19, 2025 to Mar 12, 2025
    • Start date changed from estimate of Feb 19, 2024 to Mar 12, 2024
    • Site details revised at 2 of 2 sites
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this single arm pre-test post-test design study is to test the impact of providing patients with information about community-based resources to address health-related social needs and cardiometabolic health in rural African American patients. The main question it aims to answer is: • What is the effectiveness of community resource information on patient self-efficacy to use community resources? Participants will be given: * A personalized "HealtheRx" resource with information about community resources related to food, housing, utility support, transportation, and crisis support. The HealtheRx is personalized for patients based on their age and zip code. * Access to a community resource navigator for support with using the HealtheRx upon request * 2 text messages with reminders about the HealtheRx and access to the community resource navigator
Trial Details
NCT Number NCT06264726
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Cardiovascular Diseases, Self Efficacy
Enrollment 308 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov